Τρίτη 23 Ιανουαρίου 2018

Benign and malignant tumors in Rubinstein–Taybi syndrome

Rubinstein–Taybi syndrome (RSTS) is a multiple congenital anomalies syndrome associated with mutations in CREBBP (70%) and EP300 (5–10%). Previous reports have suggested an increased incidence of specific benign and possibly also malignant tumors. We identified all known individuals diagnosed with RSTS in the Netherlands until 2015 (n = 87) and studied the incidence and character of neoplastic tumors in relation to their CREBBP/EP300 alterations. The population–based Dutch RSTS data are compared to similar data of the Dutch general population and to an overview of case reports and series of all RSTS individuals with tumors reported in the literature to date. Using the Nationwide Network and Registry of Histopathology and Cytopathology in the Netherlands (PALGA Foundation), 35 benign and malignant tumors were observed in 26/87 individuals. Meningiomas and pilomatricomas were the most frequent benign tumors and their incidence was significantly elevated in comparison to the general Dutch population. Five malignant tumors were observed in four persons with RSTS (medulloblastoma; diffuse large-cell B-cell lymphoma; breast cancer; non-small cell lung carcinoma; colon carcinoma). No clear genotype–phenotype correlation became evident. The Dutch population-based data and reported case studies underscore the increased incidence of meningiomas and pilomatricomas in individuals with RSTS. There is no supporting evidence for an increased risk for malignant tumors in individuals with RSTS, however, due to the small numbers this risk may not be fully dismissed.



from Genetics via xlomafota13 on Inoreader http://ift.tt/2Dx7cA9
via IFTTT

Clinical features, BTD gene mutations, and their functional studies of eight symptomatic patients with biotinidase deficiency from Southern China

Biotinidase (BTD) deficiency is a rare autosomal recessive metabolic disease, which develops neurological and cutaneous symptoms because of the impaired biotin recycling. Pathogenic mutations on BTD gene cause BTD deficiency. Clinical features and mutation analysis of Chinese children with BTD deficiency were rarely described. Herein, for the first time, we reported the clinical features, BTD gene mutations and their functional studies of eight symptomatic children with BTD deficiency from southern China. Fatigue, hypotonia, proximal muscular weakness, hearing deficits, rash and respiratory problems are common clinical phenotype of our patients. Seizures are observed only in patients with profound BTD deficiency. Five novel mutations were detected, among which c.637delC (H213TfsTer51) was found in 50% of our patients and might be considered as a common mutation. In vitro studies confirmed three mild mutations c.1368A>C (Q456H), c.1613G>A (R538H), and c.644T>A (L215H) which retained 10–30% of wild type enzyme activity, and six severe mutations c.235C>T (R79C), c.1271G>C (C424S), c.1412G>A (C471Y), c.637delC (H213TfsTer51), c.395T>G (M132W), c.464T>C (L155P), and c.1493dupT (L498FfsTer13) which retained <10% of wild type enzyme activity. c.1330G>C (D444H) decreased the protein expression but not activity of BTD enzyme, and H213TfsTer51 was structurally damaging while L498FfsTer13 was functionally damaging. These results will be helpful in establishing the definitive diagnosis of BTD deficiency at the gene level, offering appropriate genetic counseling, and providing clues to structure/function relationships of the enzyme.



from Genetics via xlomafota13 on Inoreader http://ift.tt/2n2OFAN
via IFTTT

Ultrasound-guided lumbar plexus block in children and adolescents using a transverse lumbar paravertebral sonogram: Initial experience

Summary

Background

The clinical reliability and reproducibility of ultrasound-guided lumbar plexus blocks is not established in pediatric populations. We present the results of a combined nerve stimulation ultrasound-guided lumbar plexus block using the vertebral body, transverse process, and psoas muscle as landmarks on a transverse lumbar paravertebral sonogram with mid-axillary transducer placement, "shamrock method," in children and adolescents.

Aims

Our primary objective was to determine the rate of achieving sensory changes in the lumbar plexus distribution. Secondary outcomes were performance time, reliability of echo-landmarks, measures of patient comfort, and complications.

Methods

We reviewed prospectively collected quality assurance data and electronic medical records of 21 patients having major orthopedic surgery with lumbar plexus block catheter for postoperative analgesia.

Results

Twenty-one patients were studied with mean age and weight (SD, range) of 13.6 years (3.8, 6-18) and 49.3 kg (18.6, 19.2-87.6). Surgical procedures included periacetabular osteotomy, pelvic osteotomy, and proximal femoral osteotomy. Mean volume of 0.5 mL/kg (0.05) 0.2% ropivacaine produced thermal sensory changes to femoral and lateral femoral cutaneous nerves in 20/21 (95% CI 0.76 to >0.99) and 19/21 (95% CI 0.70-0.99) patients. Identification of transverse process (TP), vertebral body (VB), and psoas muscle (PM): 21/21 (95% CI 0.86-1.0). Average block performance time was 9:08 minutes (2:09, 2-13). Average opioid consumption (SD) in operating room, postanesthesia care unit, 0-12 and 12-24-hour periods were 0.17 mg/kg (0.08), 0.08 mg/kg (0.06), 0.06 mg/kg (0.06), and 0.06 mg/kg (0.05). Median pain score by severity category in postanesthesia care unit: (0-3) 66.7%, (4-6) 28.5%, (>7) 4.8%; 0-12 hours: (0-3) 76.2%, (4-6) 19.0%, (>7) 4.8%; 12-24 hours: (0-3) 57.2%, (4-6) 42.8%, (>7) 0%. No complications were recorded.

Conclusion

Ultrasound guidance using lateral imaging of transverse process, vertebral body, and psoas muscle allows practitioners to reach the nerves of the lumbar plexus and achieve sensory block in pediatric patients with a high success rate.



from Anaesthesiology via xlomafota13 on Inoreader http://ift.tt/2F3UMfE
via IFTTT

Correction to: Beta2-Agonist Doping Control and Optical Isomer Challenges

Abstract

Page 1789, table 1, 'Carmoterol' row: The cell entry in the 'Stereochemistry' column, which previously read.



from Sports Medicine via xlomafota13 on Inoreader http://ift.tt/2n2UtLj
via IFTTT

Is Platelet-Rich Plasma (PRP) Effective in the Treatment of Acute Muscle Injuries? A Systematic Review and Meta-Analysis

Abstract

Background

Muscle lesions account for one-third of sport-related injuries, thus representing a substantial problem for both players and their teams. The use of platelet-rich plasma (PRP) injections is rapidly growing in clinical practice, prompted by an unmet clinical need with a large commercial market. However, after early reports of positive preliminary experience, higher quality studies recently questioned the real benefit provided by PRP injections to promote muscle healing and return to sport.

Objective

To evaluate the effect of platelet-rich plasma (PRP) injections on outcomes following acute muscle injuries.

Design

Meta-analysis of randomized, controlled trials (RCTs), Level I.

Data sources

PubMed (MEDLINE), Cochrane (CENTRAL), Web of Science, clinicaltrials.gov, who.int, isrctn.com, greylit.org, opengrey.eu.

Eligibility criteria

RCTs investigating the effect of PRP for the treatment of acute muscle injuries against at least one control group including patients treated with placebo injection or physical therapy. The outcomes evaluated were time to return to sport, re-injuries, complications, pain, muscle strength, range of motion (ROM)/flexibility, muscle function, and imaging.

Results

Six studies, involving 374 patients, were included in the meta-analysis. The time to return to sport evaluated in all six studies was significantly shorter in patients treated with PRP (mean difference = − 7.17 days). However, if only the double-blind studies (n = 2) or studies including only hamstring injuries (n = 3) were considered, non-significant differences were found. Re-injuries (relative risk = − 0.03) and complications (relative risk = 0.01) were also similar between the two groups (p > 0.05), nor were any substantial differences found regarding pain, muscle strength, ROM/flexibility, muscle function, and imaging. The performance bias was high risk due to the lack of patient blinding in four studies. The quality of evidence according to the Grading of Recommendations Assessment, Development and Evaluation (GRADE) was therefore low or very low.

Conclusions

The promising biological rationale, the positive preclinical findings, and the successful early clinical experience of PRP injections are not confirmed by the recent high-level RCTs. Therefore any benefit in terms of pain, function, return to sport, and recurrence using PRP injections for the treatment of acute muscle injuries is not supported. Due to the bias in the studies, the heterogeneity of the findings, and the limited sample size, the evidence should be considered to be of low or very low quality.



from Sports Medicine via xlomafota13 on Inoreader http://ift.tt/2DsaJM8
via IFTTT

Beyond Cut-points: Accelerometer Metrics that Capture the Physical Activity Profile

AbstractPurposeCommonly used physical activity metrics tell us little about the intensity distribution across the activity profile. The purpose of this paper is to introduce a metric, the intensity gradient, which can be used in combination with average acceleration (overall activity level) to fully describe the activity profile.Methods1669 adolescent girls (sample 1) and 295 adults with type 2 diabetes (sample 2) wore a GENEActiv accelerometer on their non-dominant wrist for up to 7-days. Body mass index and percent body fat were assessed in both samples and physical function (grip strength, Short Physical Performance Battery, sit-to-stand repetitions) in sample 2. Physical activity metrics were: average acceleration (AccelAV); the intensity gradient (IntensityGRAD from the log-log regression line: 25 mg intensity bins (x)/time accumulated in each bin (y)); total moderate-to-vigorous physical activity (MVPA); and bouted MVPA (sample 2 only).ResultsCorrelations between AccelAV and the IntensityGRAD (r=0.39-0.51) were similar to correlations between AccelAV and bouted MVPA (r=0.48), and substantially lower than between AccelAV and total MVPA (r>0.93). The IntensityGRAD was negatively associated with body fatness in sample 1 (p0.93). The IntensityGRAD was negatively associated with body fatness in sample 1 (p

from Sports Medicine via xlomafota13 on Inoreader http://ift.tt/2n4d0a7
via IFTTT

Kinetic Asymmetry during Running at Preferred and Nonpreferred Speeds

ABSTRACTPURPOSEThe aim of this study was to investigate the effect of altering preferred running speed by ±20% on kinetic asymmetry.METHODSThree-dimensional motion analysis and force data were acquired from 15 healthy males (age: 27 ± 4.6 years, height: 1.81 ± 0.09 m, mass: 80.4 ± 12.4 kg) during their preferred running speed, and at ±20% of this speed. 3T magnetic resonance images were used to measure Achilles tendon cross-sectional area and moment arm, for use in calculation of tendon stress. Kinetic and tendon stress asymmetry were subsequently calculated in each condition using the symmetry index.RESULTSAcross all joints and conditions, average asymmetry of peak moments was between ±6% but higher individual values were observed; there was no effect of speed on magnitude of asymmetry. Ground contact times, vertical ground reaction forces and support and ankle moments (maximum absolute asymmetry: 9%) were more symmetrical than hip and knee moments (up to 18%). Individual joint contribution to support moment and positive work were similar in both limbs, and ankle and hip compensatory interactions were observed with alterations in running speed. Achilles tendon stress increased with increased running speed, with higher stress in the preferred limb; asymmetry in tendon stress was not related to asymmetry in vertical ground reaction forces.CONCLUSIONResults show small effects of altering running speed on kinetic asymmetry, but responses are individual-specific with interactions occurring between joints to maintain overall movement symmetry. Further research is needed to understand the mechanical and neuromuscular mechanisms underpinning these compensations. PURPOSE The aim of this study was to investigate the effect of altering preferred running speed by ±20% on kinetic asymmetry. METHODS Three-dimensional motion analysis and force data were acquired from 15 healthy males (age: 27 ± 4.6 years, height: 1.81 ± 0.09 m, mass: 80.4 ± 12.4 kg) during their preferred running speed, and at ±20% of this speed. 3T magnetic resonance images were used to measure Achilles tendon cross-sectional area and moment arm, for use in calculation of tendon stress. Kinetic and tendon stress asymmetry were subsequently calculated in each condition using the symmetry index. RESULTS Across all joints and conditions, average asymmetry of peak moments was between ±6% but higher individual values were observed; there was no effect of speed on magnitude of asymmetry. Ground contact times, vertical ground reaction forces and support and ankle moments (maximum absolute asymmetry: 9%) were more symmetrical than hip and knee moments (up to 18%). Individual joint contribution to support moment and positive work were similar in both limbs, and ankle and hip compensatory interactions were observed with alterations in running speed. Achilles tendon stress increased with increased running speed, with higher stress in the preferred limb; asymmetry in tendon stress was not related to asymmetry in vertical ground reaction forces. CONCLUSION Results show small effects of altering running speed on kinetic asymmetry, but responses are individual-specific with interactions occurring between joints to maintain overall movement symmetry. Further research is needed to understand the mechanical and neuromuscular mechanisms underpinning these compensations. Corresponding author: Dr. Laura-Anne M Furlong, School of Sport, Exercise and Health Sciences, Loughborough University, Epinal Way, Loughborough, Leicestershire, LE11 3TU, United Kingdom, Tel: +44 (0) 1509 223059, Fax: +44 (0) 1509 226301, Email: L.A.M.Furlong@lboro.ac.uk There are no conflicts of interest associated with this research. The results of the present unfunded study do not constitute endorsement by ACSM. Results of this study are presented clearly, honestly, and without fabrication, falsification, or inappropriate data manipulation. Accepted for Publication: 11 January 2018 © 2018 American College of Sports Medicine

from Sports Medicine via xlomafota13 on Inoreader http://ift.tt/2BliLVd
via IFTTT